HELIOS Kliniken

External quality assessment in antimicrobial susceptibility testing (EUCAST disc diffusion methodology) of five anaerobic strains – performance of 35 laboratories in Germany and Austria, 2024 (2026) Buhl M, Jung J, Stingu CS, Copsey-Mawer S, Held J, Haase G, Sieg M, et al. Journal article ABC8 Consensus: Assessment by a German Group of Experts (2026) Ditsch N, Untch M, Fasching P, Briest S, Ettl J, Haidinger R, Lüftner D, et al. Journal article Guidelines for Neuroprognostication in Critically Ill Adults with Status Epilepticus (2026) Madzar D, Rajajee V, Muehlschlegel S, Wartenberg KE, Alexander SA, Busl KM, Creutzfeldt CJ, et al. Journal article Preferred working time models and equal opportunities in gynecology and obstetrics: a sub-analysis of the trinational FARBEN survey focusing on German participants from Western and Eastern federal states (2025) Tauber N, Banys-Paluchowski M, Becker C, Foessleitner P, Göpfert M, Hartmann S, Kiblawi R, et al. Journal article Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025) Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, et al. Journal article Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX) (2025) Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, et al. Journal article Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients (2025) Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, et al. Journal article S2k-Leitlinie Hilfsmittelberatung bei Harninkontinenz der DGU – Hilfsmittelrezept, Beratungsort, Beratungsgespräch, Bemusterung (2025) Wiedemann A, Manseck A, Stein J, Kirschner-Hermanns R, Froehner M, Butea-Bocu M, Fiebig C, et al. Journal article A Response to: Letter to the Editor Regarding “The Risk of Herpes Zoster in Patients with Depressive Disorders: A German Claims Database Analysis” (2025) Marijic P, Witte J, Surmann B, Batram M, Hain J, Rauschert C, Nishimwe M, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article